Fermín
Sánchez-Guijo Martín
Catedrático de Universidad
Instituto de Investigación Biomédica de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Biomédica de Salamanca (22)
2023
-
Autologous mesenchymal stromal cells embedded with Tissucol Duo® for prevention of air leak after anatomical lung resection: results of a prospective phase I/II clinical trial with long-term follow-up
Stem Cell Research and Therapy, Vol. 14, Núm. 1
-
Long-Term Results of a Phase I/II Clinical Trial of Autologous Mesenchymal Stem Cell Therapy for Femoral Head Osteonecrosis
Journal of Clinical Medicine, Vol. 12, Núm. 6
2022
-
CT-169 Cytokine Release Syndrome After Peripheral Blood Haploidentical Stem Cell Transplantation With Post-Transplant Cyclophosphamide: Time of Onset Matters
Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S437-S438
-
Eltrombopag increases the hematopoietic supporting ability of mesenchymal stem/stromal cells
Therapeutic Advances in Hematology, Vol. 13
-
External evaluation of population pharmacokinetic models of imatinib in adults diagnosed with chronic myeloid leukaemia
British Journal of Clinical Pharmacology, Vol. 88, Núm. 4, pp. 1913-1924
-
Mesenchymal Stromal Cells Combined With Elastin-Like Recombinamers Increase Angiogenesis In Vivo After Hindlimb Ischemia
Frontiers in Bioengineering and Biotechnology, Vol. 10
2021
-
CRISPR-Cas9 Technology as a Tool to Target Gene Drivers in Cancer: Proof of Concept and New Opportunities to Treat Chronic Myeloid Leukemia
CRISPR Journal, Vol. 4, Núm. 4, pp. 519-535
-
MSCs from polytrauma patients: preliminary comparative study with MSCs from elective-surgery patients
Stem Cell Research and Therapy, Vol. 12, Núm. 1
2020
-
Deciphering master gene regulators and associated networks of human mesenchymal stromal cells
Biomolecules, Vol. 10, Núm. 4
-
Inhibition of xanthine oxidoreductase enhances the potential of tyrosine kinase inhibitors against chronic myeloid leukemia
Antioxidants, Vol. 9, Núm. 1
2019
-
Deferasirox reduces oxidative DNA damage in bone marrow cells from myelodysplastic patients and improves their differentiation capacity
British Journal of Haematology, Vol. 187, Núm. 1, pp. 93-104
-
Splice donor site sgRNAs enhance CRISPR/ Cas9-mediated knockout efficiency
PLoS ONE, Vol. 14, Núm. 5
-
Subconjunctival injection of mesenchymal stromal cells protects the cornea in an experimental model of GVHD
Ocular Surface, Vol. 17, Núm. 2, pp. 285-294
2017
-
Assessment of dry eye in a GVHD murine model: Approximation through tear osmolarity measurement
Experimental Eye Research, Vol. 154, pp. 64-69
-
Regeneration of hyaline cartilage promoted by xenogeneic mesenchymal stromal cells embedded within elastin-like recombinamer-based bioactive hydrogels
Journal of Materials Science: Materials in Medicine, Vol. 28, Núm. 8
2016
-
Cardiovascular management of patients with chronic myeloid leukemia from a multidisciplinary perspective, and proposing action protocol by consensus meeting
Medicina Clinica, Vol. 146, Núm. 12, pp. 561.e1-561.e8
-
Immunomodulatory effects of bone marrow versus adipose tissue-derived mesenchymal stromal cells on NK cells: implications in the transplantation setting
European Journal of Haematology, Vol. 97, Núm. 6, pp. 528-537
-
Insights into the human mesenchymal stromal/stem cell identity through integrative transcriptomic profiling
BMC Genomics, Vol. 17, Núm. 1
-
MSC surface markers (CD44, CD73, and CD90) can identify human MSC-derived extracellular vesicles by conventional flow cytometry
Cell Communication and Signaling, Vol. 14, Núm. 1
2015
-
Incidence and risk factors for life-threatening bleeding after allogeneic stem cell transplant
British Journal of Haematology, Vol. 169, Núm. 5, pp. 719-725